Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.146 Q4 | 10 | 10 | 49 | 279 | 13 | 49 | 0.29 | 27.90 | 54.29 | |
22 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.160 Q4 | 27 | 29 | 108 | 2027 | 52 | 97 | 0.51 | 69.90 | 44.58 | |
21 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.181 Q3 | 17 | 27 | 85 | 1397 | 35 | 79 | 0.46 | 51.74 | 36.44 | |
20 | Anti-Infective Agents | journal | 0.200 Q3 | 26 | 15 | 45 | 885 | 33 | 43 | 0.70 | 59.00 | 58.62 | |
19 | Current Pharmacogenomics and Personalized Medicine | journal | 0.262 Q3 | 20 | 38 | 103 | 1871 | 117 | 80 | 1.28 | 49.24 | 53.33 | |
18 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.495 Q3 | 45 | 26 | 75 | 2332 | 108 | 69 | 1.10 | 89.69 | 37.35 | |
17 | Current Drug Safety | journal | 0.539 Q3 | 41 | 39 | 170 | 925 | 283 | 157 | 1.28 | 23.72 | 37.40 | |
16 | Current Radiopharmaceuticals | journal | 0.555 Q3 | 32 | 26 | 107 | 1359 | 162 | 98 | 1.40 | 52.27 | 39.13 | |
15 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.580 Q2 | 43 | 37 | 82 | 2080 | 143 | 79 | 1.58 | 56.22 | 40.00 | |
14 | Reviews on Recent Clinical Trials | journal | 0.611 Q2 | 35 | 21 | 95 | 788 | 166 | 92 | 1.69 | 37.52 | 20.00 | |
13 | Journal of Toxicology | journal | 0.642 Q2 | 47 | 27 | 117 | 1349 | 284 | 113 | 2.55 | 49.96 | 39.20 | |
12 | Infectious Disorders - Drug Targets | journal | 0.707 Q2 | 61 | 38 | 139 | 2911 | 264 | 125 | 1.68 | 76.61 | 37.21 | |
11 | Current Vascular Pharmacology | journal | 0.783 Q2 | 69 | 94 | 268 | 10596 | 775 | 248 | 2.82 | 112.72 | 30.09 | |
10 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q2 | 107 | 164 | 355 | 14556 | 1230 | 337 | 3.42 | 88.76 | 38.36 | |
9 | Current Neuropharmacology | journal | 0.951 Q2 | 103 | 48 | 170 | 6542 | 547 | 161 | 2.60 | 136.29 | 49.66 | |
8 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.122 Q1 | 108 | 174 | 321 | 13259 | 994 | 287 | 2.85 | 76.20 | 37.06 | |
7 | Open Medicinal Chemistry Journal | journal | 1.227 Q1 | 23 | 7 | 23 | 247 | 102 | 21 | 4.35 | 35.29 | 43.59 | |
6 | CNS and Neurological Disorders - Drug Targets | journal | 1.287 Q1 | 96 | 140 | 308 | 10449 | 972 | 269 | 2.61 | 74.64 | 42.80 | |
5 | Current Pharmaceutical Design | journal | 1.295 Q1 | 183 | 659 | 1399 | 71581 | 5281 | 1284 | 3.55 | 108.62 | 40.30 | |
4 | Current Medicinal Chemistry | journal | 1.373 Q1 | 202 | 359 | 1223 | 41513 | 5433 | 1164 | 4.02 | 115.64 | 39.58 | |
3 | Current Molecular Pharmacology | journal | 1.455 Q1 | 49 | 20 | 71 | 1907 | 251 | 65 | 2.88 | 95.35 | 35.29 | |
2 | Current Drug Targets | journal | 1.548 Q1 | 119 | 174 | 546 | 14997 | 2193 | 496 | 3.67 | 86.19 | 37.68 | |
1 | Current Cancer Drug Targets | journal | 1.585 Q1 | 103 | 82 | 269 | 8657 | 1036 | 249 | 3.79 | 105.57 | 38.44 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®